Home › Colon Cancer › Texas › Houston

Pag-aaral pangklinika para sa Colon Cancer sa Houston, TX

Isang pag-aaral para sa Colon Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Nagre-recruitPhase 1

ALX Center 5, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07085091

A Study of PHN-012 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1

PHN-012-001 Site, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07127874

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Nagre-recruitPhase 3

Oncology Consultants P.A., Houston
Oncology Consultants P.A., Houston
Texas Oncology - Gulf Coast, Houston
at 7 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222800

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2

MD Anderson, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Nagre-recruitPhase 1/2

The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07629960

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

The University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07705334

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Nagre-recruitPhase 3

Md Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07284849

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Nagre-recruitPhase 2/3

Lyndon Baines Johnson General Hospital, Houston
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Ben Taub General Hospital, Houston
at 2 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05174169

Shield Post-Approval Study Protocol

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Integrity Advanced Therapeutics, PLLC, Houston

Edad 45 hanggang 81 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06880055

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

The University of Texas - M.D. Anderson Cancer Center, Houston
The University of Texas, MD Anderson Cancer Center - West Houston, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07318805

Chronic Loose Stools Following Right-sided Hemicolectomy for Colon Cancer and the Association With Bile Acid Malabsorption and Small Intestinal Bacterial Overgrowth Using a Novel Sampling Device

Nagre-recruitObservasyonal na pag-aaral

MD Anderson Cancer Center, Houston

Edad 20 hanggang 85 · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT06927011

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Nagre-recruitPhase 1

The University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07458347

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Nagre-recruitPhase 1

Research Site, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Nagre-recruitPhase 1

University of Texas, MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT06040541

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Nagre-recruitPhase 1/2

MD Anderson Cancer Center, Houston

Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Nagre-recruitPhase 1/2

The University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT05379985

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Nagre-recruitObservasyonal na pag-aaral

M.D. Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update May 11, 2026 · NCT00843375

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06239194

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Houston

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER

Nagre-recruitPhase 2

Baylor College of Medicine, Houston

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update May 25, 2025 · NCT05870800

Pag-aaral para sa Colon Cancer sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.